logo

Bluebird Bio Inc. (BLUE)



Trade BLUE now with
  Date
  Headline
3/10/2021 7:23:39 AM Bluebird Bio Provides Updated Findings From Reported Case Of Acute Myeloid Leukemia In LentiGlobin
1/11/2021 6:37:59 AM Bluebird Bio To Retain Focus On Severe Genetic Disease And To Launch Its Oncology Business As New Entity
12/4/2020 8:06:24 AM Magenta Therapeutics And Bluebird Bio Announce A Phase 2 Trial Collaboration To Evaluate Magenta's MGTA-145
11/4/2020 5:31:19 PM Bluebird Bio Q3 Loss/Shr $2.94; Adjusts LentiGlobin BLA Submission Timing To Late 2022
10/2/2020 5:32:27 AM Bluebird Bio: EMA Accepts MAA For Investigational Elivaldogene Autotemcel Gene Therapy
8/11/2020 7:04:51 AM Bluebird Bio Appoints Denice Torres To Board
5/18/2020 9:35:45 PM Bluebird Bio Prices Underwritten Public Offering Of 9.09 Mln Shares At $55.00/shr
5/18/2020 7:03:37 AM Bluebird Bio Commences Public Offering Of $400 Mln Shares
5/11/2020 7:39:05 AM Bluebird Bio Amends Existing Co-promotion/co-development Agreement With Bristol Myers Squibb
3/26/2020 7:36:03 AM Bluebird Bio Issues Update On Business Operations And Clinical Program Development